Below are the most recent publications written about "Indenes" by people in Profiles.
-
Kurata S, Shen B, Liu JO, Takeuchi N, Kaji A, Kaji H. Possible steps of complete disassembly of post-termination complex by yeast eEF3 deduced from inhibition by translocation inhibitors. Nucleic Acids Res. 2013 Jan 07; 41(1):264-76.
-
Kumar AS, Lakshmanan V, Caplan JL, Powell D, Czymmek KJ, Levia DF, Bais HP. Rhizobacteria Bacillus subtilis restricts foliar pathogen entry through stomata. Plant J. 2012 Nov; 72(4):694-706.
-
Norris ER, Correll JR, Zemanek KJ, Lerman J, Primelo RA, Kaufmann MW. A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. J Affect Disord. 2013 Jan 10; 144(1-2):141-7.
-
Brennan JA, Graf R, Grauer SM, Navarra RL, Pulicicchio CM, Hughes ZA, Lin Q, Wantuch C, Rosenzweig-Lipson S, Pruthi F, Lai M, Smith D, Goutier W, van de Neut M, Robichaud AJ, Rotella D, Feenstra RW, Kruse C, Broqua P, Beyer CE, McCreary AC, Pausch MH, Marquis KL. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity. J Pharmacol Exp Ther. 2010 Jan; 332(1):190-201.
-
Ferrari E, Schiano N, Benhamou M, Baudouy M. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties]. Arch Mal Coeur Vaiss. 2001 Nov; 94(11 Suppl):1301-6.
-
Claudi F, Cingolani GM, Di Stefano A, Giorgioni G, Amenta F, Barili P, Ferrari F, Giuliani D. Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands. J Med Chem. 1996 Oct 11; 39(21):4238-46.
-
Petkov VD, Radomirov R, Minchev S, Petkov D, Alexiev V, Stoev S, Venkova K, Mancheva I, Stoyneva I, Petkov VV, et al. Biological tests for opiate activity of newly-synthesized compounds--opioid peptides and cyclic beta-diketones. Acta Physiol Pharmacol Bulg. 1989; 15(1):19-30.
-
Riley LJ, Vlasses PH, Rotmensch HH, Swanson BN, Chremos AN, Johnson CL, Ferguson RK. Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium diet. Nephron. 1985; 41(3):283-8.
-
Vlasses PH, Rotmensch HH, Swanson BN, Irvin JD, Johnson CL, Ferguson RK. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men. Pharmacotherapy. 1984 Sep-Oct; 4(5):272-7.
-
Swanson BN, Mojaverian P, Boppana VK. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat. J Toxicol Environ Health. 1983 Aug-Sep; 12(2-3):213-22.